The story of Qbtech (Quantitative behaviour technology) began in Gothenburg, Sweden in 2002. By developing proprietary algorithms, a unique Continuous Performance Task (CPT) and adding important activity measures, Qbtech created an objective test, QbTest, with the ability to aid in the assessment of ADHD and treatment follow-up in both clinical and research settings. In 2005, 2012 and 2014, three
major milestones occurred as QbTest received FDA clearances for diagnostic assessment and treatment follow-up, further validating Qbtech’s commitment to quality. Since 2009, Qbtech has grown significantly and our presence has expanded worldwide with local offices in the UK, Germany and the United States. So far, more than 250,000 patients have been evaluated using QbTest. As we continue to grow and get to know our customers better, we at Qbtech are proud to continue developing products that can empower well-informed decision-making. Listen to our new podcast, Rethinking ADHD, featuring renowned broadcaster Simon Mundie and public figures who have been diagnosed with the condition. Spotify: https://open.spotify.com/show/1m5L8crlecF8GVpViXhmZf?si=72bbce95f61d4291
Apple Podcasts: https://podcasts.apple.com/gb/podcast/rethinking-adhd-qbtech/id1714485901?i=1000633340161
